BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 559690)

  • 1. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes.
    Kidd GS; Dimond R; Kark JA; Whorton N; Vigersky RA
    J Clin Endocrinol Metab; 1982 Apr; 54(4):872-5. PubMed ID: 6801073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes.
    Lehtovirta P; Ranta T; Seppälä M
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):682-6. PubMed ID: 580517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Longtime study on bromoergocryptine therapy and pyridoxine therapy of amenorrhea-galactorrhea].
    Schindler AE; Plieninger M; Zubke W; Göser R; Keller E
    Arch Gynecol; 1979 Jul; 228(1-4):596. PubMed ID: 573598
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurogenic galactorrhea-amenorrhea.
    Boyd AE; Spare S; Bower B; Reichlin S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1374-7. PubMed ID: 263659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
    Hiroi M; Kawakoshi S; Kaneko N
    Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
    Baron J; Warenik-Szymankiewicz A; Chwalisz K
    Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy following thyroid hormone treatment in a patient with amenorrhea-galactorrhea due to primary hypothyroidism.
    Aono T; Shioji T; Onishi T; Kurachi H; Miyai K
    Fertil Steril; 1977 Aug; 28(8):878-80. PubMed ID: 885277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
    Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.